SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-04-005202
Filing Date
2004-09-10
Accepted
2004-09-10 09:14:02
Documents
1
Period of Report
2004-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3844
  Complete submission text file 0001140361-04-005202.txt   5759
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 210 CENTRAL PARK SOUTH NEW YORK NY 10019
KANZER STEVE H (Reporting) CIK: 0001076653 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 041024063